share_log

Bluebird Bio Q1 Sales $18.600M Miss $19.551M Estimate

Benzinga ·  May 9 07:01

bluebird bio (NASDAQ:BLUE) reported quarterly sales of $18.600 million which missed the analyst consensus estimate of $19.551 million by 4.86 percent. This is a 681.18 percent increase over sales of $2.381 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment